Last reviewed · How we verify
buprenorphine sublingual film — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
buprenorphine sublingual film (buprenorphine sublingual film) — Alar Pharmaceuticals Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| buprenorphine sublingual film TARGET | buprenorphine sublingual film | Alar Pharmaceuticals Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- buprenorphine sublingual film CI watch — RSS
- buprenorphine sublingual film CI watch — Atom
- buprenorphine sublingual film CI watch — JSON
- buprenorphine sublingual film alone — RSS
Cite this brief
Drug Landscape (2026). buprenorphine sublingual film — Competitive Intelligence Brief. https://druglandscape.com/ci/buprenorphine-sublingual-film. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab